Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMT2003 in Advanced Solid Tumors
NCT00332280Phase 3Terminated
- Sponsor
- Auron Healthcare GmbH
- Start
- May 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of AMT 2003 in solid tumor, sponsored by Auron Healthcare GmbH. Started May 2006; status: terminated.
02
Drugs
AMT 2003
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00332280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332280.